NEJM: Efficacy of Natural Immunity Against Sars-CoV-2 Reinfection with the Beta Variant
Key Point: "Protection by previous SARS-CoV-2 infection against reinfection with the beta variant was observed, even 1 year after the...
NEJM: Efficacy of Natural Immunity Against Sars-CoV-2 Reinfection with the Beta Variant
WHO Potentially Links Hearing Loss To Pfizer Vaccine (With Supporting Publication)
Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children